196 related articles for article (PubMed ID: 16151905)
1. A new fluorimetric enzyme assay for the diagnosis of Niemann-Pick A/B, with specificity of natural sphingomyelinase substrate.
van Diggelen OP; Voznyi YV; Keulemans JL; Schoonderwoerd K; Ledvinova J; Mengel E; Zschiesche M; Santer R; Harzer K
J Inherit Metab Dis; 2005; 28(5):733-41. PubMed ID: 16151905
[TBL] [Abstract][Full Text] [Related]
2. Diagnosis of Niemann-Pick disease using a simple and sensitive fluorimetric assay of sphingomyelinase activity.
Besley GT
Clin Chim Acta; 1978 Dec; 90(3):269-78. PubMed ID: 31994
[TBL] [Abstract][Full Text] [Related]
3. A practical chromogenic procedure for the detection of homozygotes and heterozygous carriers of Niemann-Pick disease.
Gal AE; Brady RO; Hibbert SR; Pentchev PG
N Engl J Med; 1975 Sep; 293(13):632-6. PubMed ID: 239343
[TBL] [Abstract][Full Text] [Related]
4. Accurate differentiation of neuronopathic and nonneuronopathic forms of Niemann-Pick disease by evaluation of the effective residual lysosomal sphingomyelinase activity in intact cells.
Graber D; Salvayre R; Levade T
J Neurochem; 1994 Sep; 63(3):1060-8. PubMed ID: 8051547
[TBL] [Abstract][Full Text] [Related]
5. Niemann-Pick disease type A and B are clinically but also enzymatically heterogeneous: pitfall in the laboratory diagnosis of sphingomyelinase deficiency associated with the mutation Q292 K.
Harzer K; Rolfs A; Bauer P; Zschiesche M; Mengel E; Backes J; Kustermann-Kuhn B; Bruchelt G; van Diggelen OP; Mayrhofer H; Krägeloh-Mann I
Neuropediatrics; 2003 Dec; 34(6):301-6. PubMed ID: 14681755
[TBL] [Abstract][Full Text] [Related]
6. Synthesis of pyrenesulfonylamido-sphingomyelin and its use as substrate for determining sphingomyelinase activity and diagnosing Niemann-Pick disease.
Klar R; Levade T; Gatt S
Clin Chim Acta; 1988 Sep; 176(3):259-67. PubMed ID: 2846208
[TBL] [Abstract][Full Text] [Related]
7. A fluorescence-based, high-performance liquid chromatographic assay to determine acid sphingomyelinase activity and diagnose types A and B Niemann-Pick disease.
He X; Chen F; Dagan A; Gatt S; Schuchman EH
Anal Biochem; 2003 Mar; 314(1):116-20. PubMed ID: 12633609
[TBL] [Abstract][Full Text] [Related]
8. Spectrum of SMPD1 mutations in Asian-Indian patients with acid sphingomyelinase (ASM)-deficient Niemann-Pick disease.
Ranganath P; Matta D; Bhavani GS; Wangnekar S; Jain JM; Verma IC; Kabra M; Puri RD; Danda S; Gupta N; Girisha KM; Sankar VH; Patil SJ; Ramadevi AR; Bhat M; Gowrishankar K; Mandal K; Aggarwal S; Tamhankar PM; Tilak P; Phadke SR; Dalal A
Am J Med Genet A; 2016 Oct; 170(10):2719-30. PubMed ID: 27338287
[TBL] [Abstract][Full Text] [Related]
9. Sphingomyelinase activities of various human tissues in control subjects and in Niemann-Pick disease - development and evaluation of a microprocedure.
Vanier MT; Revol A; Fichet M
Clin Chim Acta; 1980 Oct; 106(3):257-67. PubMed ID: 6251986
[TBL] [Abstract][Full Text] [Related]
10. Studies on sphingomyelinase and beta-glucosidase activities in Niemann-Pick disease variants. Phosphodiesterase activities measured with natural and artificial substrates.
Besley GT; Moss SE
Biochim Biophys Acta; 1983 Jun; 752(1):54-64. PubMed ID: 6303436
[TBL] [Abstract][Full Text] [Related]
11. Uptake and metabolism of radioactively labeled sphingomyelin in cultured skin fibroblasts from controls and patients with Niemann-Pick disease and other lysosomal storage diseases.
Kudoh T; Velkoff MA; Wenger DA
Biochim Biophys Acta; 1983 Nov; 754(1):82-92. PubMed ID: 6626569
[TBL] [Abstract][Full Text] [Related]
12. Sphingomyelinase activity levels in human peripheral blood leukocytes, using [3H]sphingomyelin as substrate: study of heterozygotes and homozygotes for Niemann-Pick disease variants.
Zitman D; Chazan S; Klibansky C
Clin Chim Acta; 1978 May; 86(1):37-43. PubMed ID: 26487
[TBL] [Abstract][Full Text] [Related]
13. Human acid sphingomyelinase structures provide insight to molecular basis of Niemann-Pick disease.
Zhou YF; Metcalf MC; Garman SC; Edmunds T; Qiu H; Wei RR
Nat Commun; 2016 Oct; 7():13082. PubMed ID: 27725636
[TBL] [Abstract][Full Text] [Related]
14. Retroviral-mediated transfer of the human acid sphingomyelinase cDNA: correction of the metabolic defect in cultured Niemann-Pick disease cells.
Suchi M; Dinur T; Desnick RJ; Gatt S; Pereira L; Gilboa E; Schuchman EH
Proc Natl Acad Sci U S A; 1992 Apr; 89(8):3227-31. PubMed ID: 1565614
[TBL] [Abstract][Full Text] [Related]
15. Gaucher and Niemann-Pick diseases--enzymatic diagnosis in dried blood spots on filter paper: retrospective diagnoses in newborn-screening cards.
Chamoles NA; Blanco M; Gaggioli D; Casentini C
Clin Chim Acta; 2002 Mar; 317(1-2):191-7. PubMed ID: 11814475
[TBL] [Abstract][Full Text] [Related]
16. A micromethod for sphingomyelinase assay using a chromogenic artificial substrate. Its use in the diagnosis of Niemann-Pick disease.
Den Tandt WR; Jaeken J; Leroy JG; Eggermont E
Acta Paediatr Belg; 1979; 32(4):253-8. PubMed ID: 232608
[No Abstract] [Full Text] [Related]
17. Sphingomyelinases and Niemann-Pick disease.
Levade T; Salvayre R; Douste-Blazy L
J Clin Chem Clin Biochem; 1986 Apr; 24(4):205-20. PubMed ID: 3009683
[TBL] [Abstract][Full Text] [Related]
18. An Early-Onset Neuronopathic Form of Acid Sphingomyelinase Deficiency: A SMPD1 p.C133Y Mutation in the Saposin Domain of Acid Sphingomyelinase.
Ota S; Noguchi A; Kondo D; Nakajima Y; Ito T; Arai H; Takahashi T
Tohoku J Exp Med; 2020 Jan; 250(1):5-11. PubMed ID: 31941852
[TBL] [Abstract][Full Text] [Related]
19. Clinical and biochemical diagnostics of Niemann-Pick disease.
Maciejko D; Tylki-Szymańska A
Klin Padiatr; 1986; 198(2):103-6. PubMed ID: 3009958
[TBL] [Abstract][Full Text] [Related]
20. Quantification of cellular acid sphingomyelinase and galactocerebroside beta-galactosidase activities by electrospray ionization mass spectrometry.
Zhou X; Turecek F; Scott CR; Gelb MH
Clin Chem; 2001 May; 47(5):874-81. PubMed ID: 11325891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
